Invitris vs Modulari-T

<p>Invitris is a cutting-edge biotechnology platform specializing in cell-free protein synthesis. It enables you to design, express, and scale complex proteins faster and with greater flexibility than traditional cell-based methods. With systems optimized for microbial and mammalian protein production, Invitris supports rapid workflows and high-throughput screening, letting you accelerate research and development in biopharmaceuticals, industrial biotechnology, agriculture, and antimicrobial resistance.</p> <p>It provides tools for rapid protein engineering, integrating computational design with high-throughput screening, and supports seamless scalability from picoliter reactions to large-scale manufacturing. Invitris also offers co-development and licensing partnerships to help you bring innovative biotech solutions to market efficiently. The platform is designed to streamline your protein production process with scalable, tunable, and efficient technologies tailored to a variety of life science applications.</p>

<p>Modulari-T provides cutting-edge biotechnology software solutions centered on Modular Actuation Receptor Cells (MARC), which are synthetic immune receptors designed for high efficacy and safety across diverse cell types. It enables you to leverage these receptors to improve immune cell therapies by preventing early T cell exhaustion and enhancing their persistence, making cell therapies more functional and long-lasting.</p> <p>With Modulari-T, you also gain access to the Modular Vector (MoVE) platform for in vivo delivery of these engineered receptors, targeting immune cells like T cells and NK cells. This combination offers scalable, off-the-shelf cell therapy options that are backed by peer-reviewed science, making it a promising tool for researchers and healthcare professionals working on cancer immunotherapy and advanced cell therapy development.</p>